Elevated waist-to-hip ratio, as an abdominal obesity index, predicts the risk of diabetic kidney injury

Table 2 Basic characteristics of the patients

	Con1	NAU2	MAU3	CAU
TC (mmol/L)	4.73 (4.15-5.44)	4.64 (3.94-5.32)	4.95 (4.18-5.69)	4.71 (3.84-6.42)
TG (mmol/L)	0.99 (0.74-1.40)	1.58 (1.11-2.32)1	1.79 (1.17-2.52)1	2.31 (1.79-3.09)1,2,3
LDL-C (mmol/L)	2.84 (2.40-3.57)	2.87 (2.25-3.53)	3.04 (2.28-3.56)	2.50 (1.81-4.21)
HDL-C (mmol/L)	1.39 (1.16-1.58)	0.99 (0.84-1.18)1	1.05 (0.89-1.21)1	0.95 (0.88-1.21)1
non-HDL-C (mmol/L)	3.30 (2.73-3.99)	3.65 (2.92-4.24)1	3.87 (3.02-4.57)1	3.89 (2.77-5.12)1
AIP	-0.16 (-0.32-0.06)	0.21 (0.02-0.39)1	0.22 (-0.01-0.41)1	0.33 (0.22-0.45)1,2,3
ALB (g/L)	44.05 (42.40-45.58)	41.8 (39-44.63)1	42.4 (39.3-45.7)1	39.3 (36-43)1,2,3
γ-GGT (IU/L)	18 (14-30)	31 (20-50)1	33 (20-54)1	32 (20-46)1
UA (μmol/L)	286.5 (238.75-349)	323 (273-388)1	333.5 (271.75-388.25)1	359 (317-438)1,2
Creatinine (μmol/L)	58 (51-69)	67 (60-73)1	67 (59-74)1	72 (62-78)1
BUN (mmol/L)	4.98 (4.11-5.63)	5.14 (4.26-6.09)	5.37 (4.44-6.47)1	5.9 (4.98-6.87)1,2
ALT	18 (13-26)	25 (17-39)1	23 (16-40.75)1	21 (15-31)
AST	19.5 (17-23)	19 (15-25.25)	20 (16-26)	20 (15-25)

¹P < 0.05 represented as significant vs healthy controls group.

²P < 0.05 represented as significant vs normal albuminuria group.

³P < 0.05 represented as significant vs microalbuminuria group.

Con: Healthy controls; NAU: Normal albuminuria; MAU: Microalbuminuria; CAU: Clinical proteinuria; TC: Total cholesterol; TG: Triglyceride; HDL-C: High-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol; non-HDL-C: Non-high-density lipoprotein cholesterol; AIP: The data of log (triglyceride/high-density lipoprotein cholesterol); ALB: Albumin; γ-GGT: Gamma-glutamyl transferase; ALT: Alanine aminotransferase; AST: Aspartate transaminase; BUN: Blood urea nitrogen; UA: Urine acid.